Alberto Bardelli studied Biological Sciences at the University of Turin, graduating cum laude with an honourable mention. After graduation he moved to the Ludwig Institute for Cancer Research in London where he obtained a PhD in Biochemistry and Molecular Biology from the University College London (UCL). He is a molecular geneticist and expert in the field of personalized therapies, and currently directs the IFOM Genomics of Cancer and Targeted Therapies program at the Institute for Cancer Research and Treatment in Candiolo, near Turin. Since 2005 Professor Bardelli has been an Associate Professor in the Department of Oncology, Medical School, University of Turin.
Professor Bardelli has authored more than 140 scientific articles, including 100 as an independent investigator. Discoveries from his group have led to the development of diagnostic tests, currently in clinical use, based on the genetic profiles of individual tumours. These discoveries represent the first example of personalized therapies for colorectal cancer patients, as was recently reported in Nature, JAMA, and Lancet Oncology.
Press return to search